Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
| Revenue (TTM) | $4.25B |
| Gross Profit (TTM) | $1.49B |
| EBITDA | $679.70M |
| Operating Margin | 10.20% |
| Return on Equity | -38.70% |
| Return on Assets | 2.35% |
| Revenue/Share (TTM) | $30.71 |
| Book Value | $21.33 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | 0.39 |
| EV/Revenue | 1.114 |
| EV/EBITDA | 8.41 |
| Quarterly Earnings Growth (YoY) | -63.60% |
| Quarterly Revenue Growth (YoY) | -2.50% |
| Shares Outstanding | $137.65M |
| Float | $136.81M |
| % Insiders | 0.41% |
| % Institutions | 116.11% |
Volatility is currently contracting